Connect with us

Negligence & Personal Injury

Hawaiian Man Wins $700,000 Jury Verdict for Wrongly Receiving Antipsychotic Drugs in Hospital

mm

Published

on

A federal jury has just found in favor of a Hawaiian man who sued a hospital for injecting him with antipsychotic drugs against his will.

The jury awarded more than $700,000 in damages to the man, Cameron Raymond, who was a patient at Wilcox Memorial Hospital in 2013. In his lawsuit brought in US federal district court, Mr. Raymond claimed that hospital emergency room staff injected him with drugs that rendered him incapacitated for months. After hearing evidence from both sides, the jury concluded that the hospital intentionally or, at least, recklessly inflicted emotional distress on Mr. Raymond when they gave him the drugs without his consent. The jury held unanimously that the hospital’s actions amounted to assault and battery.

The jury then granted damages in excess of $700,000, including $425,000 for punitive damages and almost $300,000 in compensatory damages to account for Mr. Raymond’s pain, suffering and emotional distress.

The case arose from an incident that occurred in June 2013 between Mr. Raymond and his ex-wife, who reportedly called the police and asked them to come to his home. According to court records, the woman said that she was concerned about Mr. Raymond’s behavior, and that she had received strange phone calls and text messages from him while he was in the custody of their children.  (Mr. Raymond, by his testimony, denies her allegations.)

After the police arrived to the home, Mr. Raymond was detained in leg and arm restraints and was driven to the emergency room of the Wilcox Memorial Hospital. There, he received an involuntary psychological evaluation, and hospital staff took his blood for testing. According to the court testimony, the blood test came back negative for illegal drugs.

Despite the negative blood test, the hospital staff determined that it was unsafe to transport Mr. Raymond to another medical center for further evaluation without his being incapacitated. Therefore, according to court records, hospital staff injected him with 2 different antipsychotic medications against his will.

As a result of these injections, Mr. Raymond was left incapacitated for months. He testified that he was forced to move in with his parents for day-to-day care, and that he could hardly move his own body for 6 months.

Wilcox Memorial Hospital declined to comment after the jury’s verdict, stating that it was still reviewing the case and the verdict with its attorneys. Mr. Raymond also declined to comment to the press following the ruling in his favor.

Comments
Continue Reading

Negligence & Personal Injury

Traumatic Brain Injury May Increase Risk of Alzheimer’s Disease

mm

Published

on

According to a new study, people who have had a history of traumatic brain injury, otherwise known as TBI, have an increased risk for developing some type of dementia, including Alzheimer’s disease. The research indicates it may accelerate the onset of the disease by about four years.

TBI and Dementia

Dementia is a general term that may include multiple diseases. All have one thing in common – they include a decline in mental ability. This decline is serious enough that it interferes with their ability to act and interact in daily life as it progresses. One of the most well-known conditions under the term dementia is Alzheimer’s disease.

The causes of dementia can vary but all are triggered by abnormal changes in the brain. They result in a loss of cognitive skills or the ability to think. The loss also impacts the person’s feelings, behaviors and even their relationships with others.

A TBI is caused by a sudden impact to the head. It can happen from a fall or car accident as well as other situations where the person hits their head. A person who experiences a TBI may lose consciousness even for only a few seconds. They may suffer from other symptoms:

  • Confusion
  • Trouble speaking clearly
  • Unable to recall the event that caused the TBI
  • Difficulty learning or remembering new information
  • Lack of coordination
  • Difficulty seeing clearly
  • Trouble hearing or ringing in the ears
  • Unsteady when walking or standing

A TBI can cause issues even years later when the person seems to have recovered from the injury. A doctor will label a TBI as mild, moderate or severe based on various factors, including how long they were unconscious and severity of other symptoms. However, it is important to understand that even a mild TBI can have serious effects that are long-lasting.

Mild to Severe TBIs

A mild TBI is known as a concussion and it doesn’t result in unconsciousness at all or for more than 30 minutes. The person may experience dizziness or a headache, nausea and confusion, but the symptoms go away in a few hours or days. However, in some cases, they can last for several months.

A moderate TBI causes unconsciousness that lasts between 30 minutes and 24 hours with a severe TBI being over 24 hours of unconsciousness. They have the same symptoms as the mild version, only stronger and may last longer.

The ability to learn new information or remember things and to pay attention are symptoms that can be long-lasting or permanent from a TBI. The person may have difficulty organizing their thoughts or being able to create a plan.

Research in the past had linked moderate to severe TBIs with dementia. New research shows that even a mild TBI or repeated mild TBIs may result in an increased risk for developing some type of dementia. Research shows that a protein seen in Alzheimer’s patients is evident within hours of a mild TBI event. Not everyone who has a TBI will develop dementia, but it is important to be aware of the risk.

Comments
Continue Reading

Defective Products

Bayer Settles 90% of U.S. Essure Claims for 1.6 Billion

mm

Published

on

About 90 percent of the more than 39,000 lawsuits filed against Bayer over Essure injuries have been resolved by a $1.6 billion settlement. Bayer said in a statement that the settlement resolves most filed and unfiled cases and that it continues to work with plaintiff’s lawyers to resolve the remaining cases.

FDA Actions and Essure Injury Complaints

The settlement comes after years of complains of adverse events involving the metal coils which are placed in the fallopian tubes. Some of these complaints say that the coils can perforate the tubes, tear the uterus, and that the coils can break causing little metal shards to migrate elsewhere in the body. Women have also complained of heavy bleeding, pain, and other side effects that the patients were forced to undergo hysterectomy.

In 2018, the U.S. Food and Drug Administration placed restrictions on the device and required patients to review the Patient- Doctor Discussion Checklist and sign prior to being implanted with the birth control device. Bayer made the decision to stop selling Essure in the United States not long after citing declining sales.

Post-Market Surveillance Reports

The required 522 study, a post-marketing surveillance plan, was also extended by the FDA from three to five years. The FDA published the first spreadsheet of Essure adverse events on August 11, 2020, which includes events that Bayer knew or learns of during the period of November 2016 to November 2020.

The first spreadsheet includes more than 1,400 events including pain, device fragments, pregnancy, and organ perforations, including 1376 reports of serious injury, 53 reports of death and 24 reports of malfunction.

Essure Lawsuit Settlement

Many of the plaintiffs alleged in court filings that Bayer knew or should have known about the risk of adverse events, including organ perforation, device breakage, and device migration. They also allege that Essure birth control was improperly design and can break and migrate after being implanted. They accused Bayer of misrepresenting the efficacy and safety of the contraceptive device and Women who suffered Essure injuries alleged in court filings that Bayer concealed the risks and dangers of the device from the FDA, the medical community and from the women who relied on the device.

Many of the terms of the settlement are confidential, and Bayer did not admit to any wrongdoing in the court filings.

Comments
Continue Reading

Negligence & Personal Injury

The Ties Between Roundup and Cancer

mm

Published

on

Roundup is a weed killer used on farms throughout the United States. However, studies have been done which show this is a dangerous product with many side effects. One of those side effects is cancer, which can be fatal. In fact, numerous lawsuits have been filed against Monsanto, the maker of Roundup.

Types of Cancer Caused by Roundup

Much research has been done to link Roundup to certain types of cancer. One of the most well-known is Non-Hodgkin’s lymphoma. However, it is also tied to several others, including:

  • Renal cell carcinoma
  • Skin tumors
  • Hairy cell leukemia
  • Various types of lymphoma
  • Chronic lymphocytic leukemia
  • Pancreatic islet cell tumors

There is also some support that Roundup may cause damage to DNA and chromosomes. Some believe it may also create a higher risk for Parkinson’s disease.

What is Roundup?

Roundup is a weed killer manufactured by Monsanto since the 1970s when it was first introduced. It was so successful at killing weeds without harming the crops that it has become the most widely used product for weed control throughout the world.

Monsanto is also one of the engineers of seeds, and it has developed crops that are resistant to glyphosate, the active ingredient found in Roundup. Farmers can spray the fields with Roundup and not hurt the crops while getting rid of weeds.

The weeds have developed a resistance to glyphosate, which means the product must be sprayed more heavily. This has caused a higher exposure to the product for farmers.

Numerous studies have been released on the risks associated with Roundup and other weed killers. One such study was done by the International Agency for Research on Cancer (IARC), and they looked at five different pesticides to determine if they could cause cancer. From the research conducted, glyphosate was labeled as probably carcinogenic for people.

The studies came from agricultural exposure of people in the US as well as in Canada and Sweden. There was also evidence that the ingredient in Roundup could cause cancer in lab animals.

More research is being done to determine what levels of exposure can increase the risk for developing these types of cancer. The US Environmental Protection Agency conducted their own study in 1995 and labeled as probably carcinogenic for humans. The agency has changed its position and now states that it is not a carcinogen. In fact, it says Roundup is low toxicity if it’s used as directed.

The EPA drafted another assessment in December of 2017 that went even further to say there was no toxicity towards animals – even birds within their normal environment.

Lawsuits Filed

More than 800 lawsuits have been filed against Monsanto since the IARC report was released. They are claiming that the manufacturer should have warned users about the risks of using the product instead of promoting it as safe.

According to many of the claimants, they did not wear protective clothing and gear when spraying Roundup. In fact, some of them were directly exposed when the spray accidentally got on their skin. People from all over the country have been exposed, on large agricultural farms and in small backyards.

While Monsanto is the producer of Roundup, which is the top-used pesticide in the world, it is not the only company that manufacturers weed killers with the same active ingredient. However, lawsuits claim that it is not just the glyphosate that is the cause of the cancers. It is the mix of other ingredients, such as animal fats, that increase the carcinogenic properties of the chemical.

The situation is not a simple one as many other reports show a different view. In fact, over 800 studies have been done to show the safety of glyphosate, according to Monsanto. One such agency, the European Chemicals Agency, stated that the ingredient is not classified as carcinogenic. Other reports from Japan, Australia, New Zealand, Canada, Europe and even the United States support that claim.

The first trial against Monsanto was held in California with a verdict coming in August 2018. The verdict was for $289 million but was reduced to $78 million. It did hold the manufacturer responsible for a plaintiff with Non-Hodgkin’s lymphoma. Punitive damages were also awarded.

The second trial, which was also the first federal trial also provided a victory for the plaintiff with payment of $80 million ordered. More lawsuits will likely be forthcoming given the verdicts already received.

Monsanto still maintains that the pesticide is safe for use on weeds when label instructions are followed.

Comments
Continue Reading

Trending